Applies to vibegron: oral tablet.
Genitourinary
Common (1% to 10%): Urinary tract infection (6.6%), urinary retention (<2%), residual urine volume increased (<2%)[Ref]
Hematologic
Common (1% to 10%): Hot flash (<2%)[Ref]
Respiratory
Common (1% to 10%): Upper respiratory tract infection (2 %), nasopharyngitis (2.8%)[Ref]
Nervous system
Common (1% to 10%): Headache (4%)[Ref]
Gastrointestinal
Common (1% to 10%): Diarrhea (2.2%), constipation (<2%), nausea (2.2%), dry mouth (<2%)[Ref]
Dermatologic
Postmarketing reports: Pruritus, rash, drug eruption, eczema[Ref]
Frequently asked questions
- How long does it take for Gemtesa (vibegron) to work?
- How does Gemtesa (vibegron) work?
